Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease

Bibliographic Details
Main Authors:	Agustin Cota-Coronado, Lachlan H Thompson, N Emmanuel Diaz-Martinez
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=2;spage=255;epage=256;aulast=Cota-Coronado

Similar Items

Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells
by: V. Valadez-Barba, et al.
Published: (2023-11-01)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
by: David A Yefroyev, et al.
Published: (2022-01-01)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
by: Asuka Morizane
Published: (2023-02-01)

Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms
by: Agustín Cota-Coronado, et al.
Published: (2020-03-01)

Transcriptional Profiling of Xenogeneic Transplants: Examining Human Pluripotent Stem Cell-Derived Grafts in the Rodent Brain
by: Christopher R. Bye, et al.
Published: (2019-11-01)

Can pluripotent/multipotent stem cells reverse Parkinson’s disease progression?
by: Yongkang Wu, et al.
Published: (2024-01-01)

Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells
by: Lachlan H. Thompson, et al.
Published: (2015-07-01)

Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations
by: Muwan Chen, et al.
Published: (2020-01-01)

Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
by: Theo Stoddard-Bennett, et al.
Published: (2019-01-01)

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
by: Tae Wan Kim, et al.
Published: (2020-08-01)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
by: Angeliki Spathopoulou, et al.
Published: (2022-01-01)

Highly Pluripotent Adipose-Derived Stem Cell–Enriched Nanofat: A Novel Translational System in Stem Cell Therapy
by: Lindsey Alejandra Quintero Sierra, et al.
Published: (2023-05-01)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
by: Beevers, J, et al.
Published: (2013)

Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
by: Jeffrey Kim, et al.
Published: (2022-10-01)

Challenges involved in cell therapy for Parkinson’s disease using human pluripotent stem cells
by: Heechang Moon, et al.
Published: (2023-10-01)

Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease
by: Ekaterina Savchenko, et al.
Published: (2018-03-01)

Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations
by: Fabiano A. Tofoli, et al.
Published: (2019-08-01)

Generation of a human induced pluripotent stem cell line (UNAMi001-A) from a Mexican patient with sporadic Parkinson’s disease
by: Xóchitl Flores-Ponce, et al.
Published: (2022-12-01)

Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease
by: Xiangyu Zheng, et al.
Published: (2017-08-01)

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
by: Georgia Kouroupi, et al.
Published: (2020-09-01)

Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
by: Soldner, Frank, et al.
Published: (2015)

Investigation of neuronal dysfunction in Parkinson's disease using advanced physiological induced pluripotent stem cells
by: Do, B
Published: (2022)

Optical genome mapping of structural variants in Parkinson’s disease-related induced pluripotent stem cells
by: Trinh, J, et al.
Published: (2024)

Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease
by: Faria Zafar, et al.
Published: (2022-04-01)

Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
by: Pascale Baden, et al.
Published: (2019-07-01)

Enriched Differentiation of Human Otic Sensory Progenitor Cells Derived From Induced Pluripotent Stem Cells
by: Hanae Lahlou, et al.
Published: (2018-12-01)

An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions
by: Carlos W. Gantner, et al.
Published: (2020-09-01)

Enrichment of Pluripotent Stem Cell-Derived Hepatocyte-Like Cells by Ammonia Treatment.
by: Daihachiro Tomotsune, et al.
Published: (2016-01-01)

Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson’s disease
by: Yanlin Wang, et al.
Published: (2018-10-01)

Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
by: Nadja Gustavsson, et al.
Published: (2019-01-01)

Power-laws and the use of pluripotent stem cell lines.
by: Bernhard M Schuldt, et al.
Published: (2013-01-01)

Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson’s Disease, and Huntington’s Disease
by: Reed Berlet, et al.
Published: (2022-03-01)

Generation of CSi001-A, a transgene-free, induced pluripotent stem cell line derived from a Parkinson Disease (PD) patient
by: Zongbo Zhao, et al.
Published: (2018-12-01)

Establishment and characterization of human induced pluripotent stem cell line from a Parkinson’s disease patient harboring VPS13A gene mutation
by: Xianjie Lu, et al.
Published: (2022-04-01)

Establishment human induced pluripotent stem cell line from idiopathic non-familial Parkinson’s disease patient using self-replicating RNA vector
by: Harry Murti, et al.
Published: (2021-01-01)

Derivation of human induced pluripotent stem cell (iPSC) line from a 79 year old sporadic male Parkinson's disease patient
by: Shaokun Zhang, et al.
Published: (2017-03-01)

Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant
by: Yu-Che Cheng, et al.
Published: (2018-04-01)

Pluripotent Stem Cells as a Model for Human Embryogenesis
by: Daniela Ávila-González, et al.
Published: (2023-04-01)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
by: Yong Hui Koh, et al.
Published: (2018-11-01)

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
by: Daisuke Doi, et al.
Published: (2020-07-01)